Kinetic Analysis Due to Foot Dysfunction

Amputation Clinical Trial

Official title:

Analysis of Gait Kinetics in Patients With Foot Dysfunction Either Physiological or Anatomical

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05161364
• Other study ID #: 0224786
• Status: Completed
• Start date: September 13, 2021
• Est. completion date: March 1, 2022

Study information

• Verified date: December 2021
• Source: Delta University for Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of the current study is to examine the biomechanical changes of gait kinetics in patients with either partial foot amputation or peripheral neuropathy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: March 1, 2022
• Est. primary completion date: January 1, 2022
• Gender: All
• Age group: 40 Years to 65 Years

Eligibility

Inclusion Criteria:

• Partial foot amputees who didn"t receive physiotherapy and don"t use prosthesis. patients with PN grade (1-2) Age 40-65y Both sexes. Walking independently however, no walking aids were used during the testing procedures

Exclusion Criteria:

• Foot amputation levels more proximal than tarso metatarsal joint. Less than 4 months after partial foot amputation. Foot amputees who use prosthesis or suffer from phantom pain. Active foot problems; ulcer, infection, or gangrene. Patients with PN who received physiotherapy or injections like Puerarin Major surgeries in lower limb that could affect either gait or balance like ACL, hip/knee arthroplasty Spine problems that could affect either gait or balance History of ankle sprain. Pathologies such as skin diseases, inflammatory diseases, congenital diseases, or neurological diseases rather than PN.

Fractures or dislocations. Symptomatic degenerative changes that require medications. BMI over 35. Inability of walking independently

Related Conditions & MeSH terms

• Amputation
• Neuropathy;Peripheral
• Peripheral Nervous System Diseases

Locations

Country	Name	City	State
Egypt	Delta university	Gamasa	Eldakahlyia

Sponsors (1)

Lead Sponsor	Collaborator
Delta University for Science and Technology

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	GRF	Ground Reaction Force	5 minutes
Primary	Planter Pressure	Peak Planter Pressure	3 minutes
Primary	Planter Pressure distribution	Planter Pressure distribution	4 minutes
Primary	Foot surface area	Foot surface area	6 minutes